Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 5,714 shares at $24.15 ($138K) on 2023-08-10, disclosed to the SEC on 2023-08-14.
Seasonal sale ($138k) by Chief Medical Officer — this insider has traded DNLI in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.15 | 2,857 | $69K | 50.0% |
| 2 | $24.15 | 2,857 | $69K | 50.0% |
| Total | $24.15 avg | 5,714 | $138K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |